Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform
Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States ...
BioPharma Dive52m
Certis Oncology Announces Issuance of U.S. Patent for its Proprietary CertisAI Predictive Oncology Intelligence Platform™
San Diego, CA — February 12, 2025 — Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States Patent and Trademark Office (USPTO) has ...